Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Deborah D. Jeanfavre"'
Autor:
Michael P. Winters, Renee L. DesJarlais, Mark Bobko, John P. Wolak, Ho Yin Lo, Steven S. Pullen, Deborah D. Jeanfavre, Hnin Hnin Khine, Rosemarie H. Sallati, Ernest L. Raymond, Mohammed A. Kashem, Lei Qiao, Gregory P. Roth, Declan Ryan, Joseph R. Woska, Kevin J. Moriarty, Darius Robinson, Hidenori Takahashi, B. Tomczuk, Wilson Matthew Allan, Ronald L. Magolda, Peter Allen Nemoto, Andre White, Brian Nicholas Cook
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:5545-5549
A series of novel potent benzimidazole based inhibitors of interleukin-2 T-cell kinase (Itk) were prepared. In this report, we discuss the structure-activity relationship (SAR), selectivity, and cell-based activity for the series. We also discuss the
Autor:
Kathy O’Shea, Denice M. Spero, Ronald L. Magolda, Mario G. Cardozo, Lisa H. Liu, Hanbo Hu, Derek Cogan, Heather Grbic, Thomas M. Farrell, John P. Wolak, John D. Ginn, Della White, Deborah D. Jeanfavre, Mohammed A. Kashem, Maryanne L. Brown, Anthony S. Prokopowicz, Carol Ann Homon, Erick R. R. Young, Joseph R. Woska, Paul Kaplita, Darren Disalvo, Georg Dahmann, Charles L. Cywin
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:225-230
An uHTS campaign was performed to identify selective inhibitors of PKC-theta. Initial triaging of the hit set based on selectivity and historical analysis led to the identification of 2,4-diamino-5-nitropyrimidines as potent and selective PKC-theta i
Autor:
Sudha Desai, Patricia L. Reilly, Deborah D. Jeanfavre, Gerald Nabozny, Terence A. Kelly, Lemieux Rene M, Maret Panzenbeck
Publikováno v:
European Journal of Pharmacology. 534:233-240
Compound I, a novel small molecule antagonist (Kd=6 nM) of human lymphocyte function-associated antigen-1 (LFA-1, CD11a/CD18) was tested for activity in a humanized mouse model of delayed-type hypersensitivity (trans vivo delayed-type hypersensitivit
Autor:
Patricia L. Reilly, Charles Kennedy, Joseph R. Woska, Barbara-Jean Bormann, Christopher Pargellis, Jay Prendergast, Deborah D. Jeanfavre, Carol Stearns, Randall W. Barton
Publikováno v:
Biochemical Pharmacology. 52:1757-1765
CD26 and ecto-adenosine deaminase (ADA) are found associated on the plasma membrane of T lymphocytes and each possess distinct catalytic activities. CD26 has a proteolytic activity identical to dipep-tidylpeptidase IV (DPPIV; E.C. 3.4.14.5), and ecto
Autor:
Stanley Kugler, Mohammed A. Kashem, Ernest L. Raymond, Hidenori Takahashi, Steven S. Pullen, Leslie Martin, Gabriel Labissiere, Jennifer Ahlberg, Jennifer A. Kowalski, Hnin Hnin Khine, Joseph R. Woska, Stéphane De Lombaert, Donna Skow, David S. Thomson, Kathy O’Shea, Brian Nicholas Cook, Renee Zindell, Deborah D. Jeanfavre, Doris Riether, Jörg Bentzien, Kerry L. M. Ralph, Rosemarie Sellati
Publikováno v:
Bioorganicmedicinal chemistry letters. 19(6)
Benzamide 1 demonstrated good potency as a selective ITK inhibitor, however the amide moiety was found to be hydrolytically labile in vivo, resulting in low oral exposure and the generation of mutagenic aromatic amine metabolites. Replacing the benza
Autor:
Vincent J. Merluzzi, Ronald B. Faanes, Kathleen Last-Barney, Deborah D. Jeanfavre, Eugene J. McNally, Steven D. Marlin, Carol Cahill
Publikováno v:
Journal of Virological Methods. 35:255-264
Soluble intercellular adhesion molecule-1 (sICAM-1) was shown to be the receptor for the major subgroup of rhinoviruses. It was demonstrated that this molecule can inhibit the binding and subsequent infection of target cells by rhinoviruses belonging
Autor:
Gary O. Caviness, Mark E. Labadia, Maurice M. Morelock, Joseph R. Woska, Deborah D. Jeanfavre, Kathleen Last-Barney, Patricia Giblin
Publikováno v:
Biochemical pharmacology. 74(1)
Molecular K(d) and k(off) parameters are often used to define the molecular potency of drugs. These constants, however, are determined on purified target proteins, and their relationship to in vivo binding phenomena is poorly understood. Herein, we r
Autor:
Ian Potocki, Shirlynn Chen, Rosemarie Sellati, Patricia L. Reilly, Kei Kishimoto, Emeigh Jonathan Emilian, Gerald Nabozny, Robert Rothlein, Donghong A. Gao, Miao Clara K, Daniel R. Goldberg, Sorcek Ronald J, Daniel Kuzmich, Terence A. Kelly, Drané O'Brien, Deborah D. Jeanfavre, Charline Peng, and Stephen H. Norris, Kevin Chungeng Qian, Elizabeth Mainolfi, Wu Jiang-Ping, Joseph R. Woska, Jocelyn A. Gunn
Publikováno v:
Journal of medicinal chemistry. 47(22)
A novel class of lymphocyte function-associated antigen-1 (LFA-1) inhibitors is described. Discovered during the process to improve the physicochemical and metabolic properties of BIRT377 (1, Figure 1), a previously reported hydantoin-based LFA-1 inh
Autor:
Robert Rothlein, Maret Panzenbeck, Elizabeth Mainolfi, Terence A. Kelly, Rachel R. Kroe, Gary O. Caviness, Kathleen Last-Barney, Joseph R. Woska, Deborah D. Jeanfavre, Patricia Giblin, Steven E. Fogal, Patricia L. Reilly, Takashi Kei Kishimoto
Publikováno v:
Journal of immunological methods. 277(1-2)
The beta(2) integrin LFA-1 (CD11a/CD18) is a leukocyte-specific adhesion molecule that mediates leukocyte extravasation, antigen presentation, and T-cell-mediated cytolysis through its interaction with its counter-receptors, ICAM-1, ICAM-2, and ICAM-
Autor:
Walter Davidson, Jerry L. Hopkins, Deborah D. Jeanfavre, Kathleen Last Barney, Terence A. Kelly, Christine A. Grygon
Publikováno v:
Journal of the American Society for Mass Spectrometry. 14(1)
The allosteric inhibition of the lymphocyte function associated antigen-1/intercellullar adhesion molecule (LFA-1/ICAM-1) interaction, by a class of small molecules, is characterized by a battery of mass spectrometric techniques. Binding of hydantoin